| Deler fremragende | 160,980,024 shares |
| Insideraktier | 30.994.380 shares |
| Insider ejerskab | 19,25 % |
| Total Insiders | 35 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Cogent Biosciences, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Jorn Aldag | 40.090 | ||
|
Atlas Venture Associates IX, L.P.
10% Owner -
|
3.361.535 | 3.361.535 | |
|
Atlas Venture Associates IX, LLC
10% Owner -
|
3.361.535 | 3.361.535 | |
|
Atlas Venture Fund IX, L.P.
10% Owner -
|
3.361.535 | 3.361.535 | |
| Bruce Booth Director - [D] | 3.361.535 | 3.361.535 | |
| Cain Christopher W. | 28.661 | ||
|
Dario Campana
10% Owner -
|
3.095.114 | 773.778 | |
| Seth Ettenberg Chief Scientific Officer - [O] | 0 | 0 | |
| Ltd FIL - | 1.138.274 | 1.138.274 | |
| FMR LLC / Fidelity Management & Research - | 23.240 | 23.240 | |
| Fairmount Funds Management LLC Director - [D] | 5.503.418 | 5.503.418 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Karen Jean Ferrante | 2.753 | ||
| Green John L. Chief Financial Officer - [O] | 131.834 | 131.834 | |
| Geoffrey Hodge | 112.400 | ||
| Peter Evan Harwin | 28.661 | ||
| Evan Kearns Chief Legal Officer - [O] | 109.398 | 109.398 | |
|
Bong Y Koh
10% Owner -
|
4.355.273 | 4.355.273 | |
| Arlene Morris | 14.331 | ||
| Matthew Scott Osborne | 160.400 | ||
| Robert J Perez | 7.131 | ||
| Cole Pinnow Chief Commercial Officer - [O] | 216.650 | 216.650 | |
| Liam Ratcliffe Director - [D] | 897.773 | 897.773 | |
| Andrew R Robbins President and CEO, Director - [D] [O] | 657.503 | 657.503 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| John Edward Robinson Chief Scientific Officer - [O] | 140.002 | 140.002 | |
| Matthew Ros | 2.650 | ||
| Jessica Sachs Chief Medical Officer - [O] | 133.938 | 133.938 | |
|
Nimish P Shah
10% Owner -
|
3.904.273 | 4.355.273 | |
| Michael Vasconcelles | 61.900 | ||
|
VHCP Co-Investment Holdings II, LLC
10% Owner -
|
4.355.273 | 4.355.273 | |
|
VHCP Co-Investment Holdings III, LLC
10% Owner -
|
4.355.273 | 4.355.273 | |
|
VHCP Management II, LLC
10% Owner -
|
4.355.273 | 4.355.273 | |
|
VHCP Management III, LLC
10% Owner -
|
4.355.273 | 4.355.273 | |
|
Venrock Healthcare Capital Partners II, L.P.
10% Owner -
|
4.355.273 | 4.355.273 | |
|
Venrock Healthcare Capital Partners III, L.P.
10% Owner -
|
4.355.273 | 4.355.273 | |
| Charles Wilson Chief Executive Officer, Director - [D] [O] | 10.190.228 | 10.190.228 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i COGT / Cogent Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i COGT / Cogent Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2026-03-31 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 34,6600 | -7.000.000 | -242.620 | 5.503.418 | ||||
| 2026-03-31 | 2026-03-31 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 7.000.000 | 12.503.418 | ||||||
| 2026-01-22 | 2026-01-22 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 36,4000 | -3.500.000 | -127.400 | 5.503.418 | ||||
| 2025-12-30 | 2025-12-26 | 4 | Green John L. | COGT | Common Stock | D | 38,6800 | -77.000 | -2.978 | 131.834 | ||||
| 2025-12-30 | 2025-12-26 | 4 | Robinson John Edward | COGT | Common Stock | D | 38,7400 | -90.000 | -3.487 | 140.002 | ||||
| 2025-12-30 | 2025-12-26 | 4 | Sachs Jessica | COGT | Common Stock | D | 38,7000 | -82.642 | -3.198 | 133.938 | ||||
| 2025-12-30 | 2025-12-26 | 4 | Kearns Evan | COGT | Common Stock | D | 38,7000 | -65.000 | -2.516 | 109.398 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Green John L. | COGT | Common Stock | D | 39,4500 | -145.007 | -5.721 | 208.834 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Green John L. | COGT | Common Stock | D | 300.000 | 353.841 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Green John L. | COGT | Common Stock | D | 50.000 | 53.841 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Sachs Jessica | COGT | Common Stock | D | 39,4500 | -154.716 | -6.104 | 216.580 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Sachs Jessica | COGT | Common Stock | D | 320.000 | 371.296 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Sachs Jessica | COGT | Common Stock | D | 50.000 | 51.296 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Kearns Evan | COGT | Common Stock | D | 39,4500 | -125.602 | -4.955 | 174.398 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Kearns Evan | COGT | Common Stock | D | 260.000 | 300.000 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Kearns Evan | COGT | Common Stock | D | 40.000 | 40.000 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Pinnow Cole | COGT | Common Stock | D | 39,4500 | -94.800 | -3.740 | 216.650 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Pinnow Cole | COGT | Common Stock | D | 214.000 | 311.450 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Pinnow Cole | COGT | Common Stock | D | 50.000 | 97.450 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Robbins Andrew R | COGT | Common Stock | D | 39,4500 | -367.497 | -14.498 | 657.503 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Robbins Andrew R | COGT | Common Stock | D | 840.000 | 1.025.000 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Robbins Andrew R | COGT | Common Stock | D | 185.000 | 185.000 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Robinson John Edward | COGT | Common Stock | D | 39,4500 | -139.998 | -5.523 | 230.002 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Robinson John Edward | COGT | Common Stock | D | 320.000 | 370.000 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Robinson John Edward | COGT | Common Stock | D | 50.000 | 50.000 | ||||||
| 2025-07-14 | 2025-07-10 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 9,0000 | 2.777.777 | 25.000 | 9.003.418 | ||||
| 2025-01-15 | 2025-01-14 | 4 | Pinnow Cole | COGT | Common Stock | D | 7,5980 | 43.750 | 332 | 45.848 | ||||
| 2024-06-12 | 2024-06-10 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 1.500.000 | 6.225.641 | ||||||
| 2024-05-29 | 3 | Pinnow Cole | COGT | Common Stock | D | 700 | ||||||||
| 2024-04-01 | 2024-03-28 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 286.851 | 4.725.641 | ||||||
| 2024-04-01 | 2024-03-28 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | COGT | Common Stock | I | -286.851 | 0 | ||||||
| 2024-02-16 | 2024-02-16 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 7,5000 | 1.166.666 | 8.750 | 4.438.790 | ||||
| 2023-06-13 | 2023-06-09 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 12,0000 | 800.000 | 9.600 | 3.272.124 | ||||
| 2022-07-01 | 2022-06-30 | 4 | Sachs Jessica | COGT | Common Stock | D | 7,3950 | 622 | 5 | 622 | ||||
| 2022-06-21 | 2022-06-16 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | COGT | Common Stock | I | 8,2500 | 1.200.000 | 9.900 | 2.472.124 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 7,92 | 4,8600 | 2.650 | 13 | 2.650 | |||
| 2022-04-05 | 2022-04-01 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 7,92 | 4,8600 | 2.753 | 13 | 2.753 | |||
| 2022-01-27 | 2022-01-25 | 4 | Green John L. | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 225.000 | 1.112 | 225.000 | |||
| 2022-01-27 | 2022-01-25 | 4 | Sachs Jessica | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 250.000 | 1.236 | 250.000 | |||
| 2022-01-27 | 2022-01-25 | 4 | Kearns Evan | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 202.250 | 1.000 | 202.250 | |||
| 2022-01-27 | 2022-01-25 | 4 | Robinson John Edward | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 250.000 | 1.236 | 250.000 | |||
| 2022-01-27 | 2022-01-25 | 4 | Robbins Andrew R | COGT | Stock Option (Right to Buy) | D | 7,60 | 4,9432 | 690.000 | 3.411 | 690.000 | |||
| 2022-01-04 | 2022-01-03 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 8,70 | 5,1530 | 2.329 | 12 | 2.329 | |||
| 2022-01-04 | 2021-12-31 | 4 | Sachs Jessica | COGT | Common Stock | D | 6,8170 | 674 | 5 | 674 | ||||
| 2022-01-04 | 2022-01-03 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 8,70 | 5,1530 | 2.256 | 12 | 2.256 | |||
| 2021-10-05 | 2021-10-01 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 8,54 | 5,0317 | 2.385 | 12 | 2.385 | |||
| 2021-10-05 | 2021-10-01 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 8,54 | 5,0317 | 2.463 | 12 | 2.463 | |||
| 2021-07-06 | 2021-07-01 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 8,02 | 4,7754 | 2.225 | 11 | 2.225 | |||
| 2021-07-06 | 2021-07-01 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 8,02 | 4,7754 | 2.513 | 12 | 2.513 | |||
| 2021-05-05 | 2021-05-03 | 4 | Kearns Evan | COGT | Stock Option (Right to Buy) | D | 8,93 | 260.000 | 260.000 | |||||
| 2021-04-28 | 2021-04-26 | 4 | Green John L. | COGT | Common Stock | D | 8,8600 | -17.813 | -158 | 3.841 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 9,08 | 5,6577 | 2.121 | 12 | 2.121 | |||
| 2021-04-05 | 2021-04-01 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 9,08 | 5,6557 | 2.068 | 12 | 2.068 | |||
| 2021-03-15 | 2021-03-11 | 4 | Harwin Peter Evan | COGT | Stock Option (Right to Buy) | D | 8,45 | 60.000 | 60.000 | |||||
| 2021-03-15 | 2021-03-11 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 8,45 | 60.000 | 60.000 | |||||
| 2021-03-15 | 2021-03-11 | 4 | CAIN CHRISTOPHER W. | COGT | Stock Option (Right to Buy) | D | 8,45 | 60.000 | 60.000 | |||||
| 2021-03-15 | 2021-03-11 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 8,45 | 60.000 | 60.000 | |||||
| 2021-03-15 | 2021-03-11 | 4 | Shegog Todd | COGT | Stock Option (Right to Buy) | D | 8,45 | 22.500 | 22.500 | |||||
| 2021-03-15 | 2021-03-11 | 4 | Morris Arlene | COGT | Stock Option (Right to Buy) | D | 8,45 | 60.000 | 60.000 | |||||
| 2021-03-01 | 2021-02-25 | 4 | Green John L. | COGT | Common Stock | D | 524 | 21.654 | ||||||
| 2021-02-24 | 2021-02-22 | 4 | Shegog Todd | COGT | Stock Option (Right to Buy) | D | 8,59 | 37.500 | 37.500 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Robbins Andrew R | COGT | Stock Option (Right to Buy) | D | 10,17 | 315.200 | 315.200 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Green John L. | COGT | Stock Option (Right to Buy) | D | 10,17 | 270.746 | 270.746 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Green John L. | COGT | Stock Option (Right to Buy) | D | 10,17 | 111.300 | 111.300 | |||||
| 2021-02-12 | 2021-02-10 | 4 | Sachs Jessica | COGT | Stock Option (Right to Buy) | D | 10,17 | 126.500 | 126.500 | |||||
| 2021-02-02 | 2021-02-01 | 4 | Sachs Jessica | COGT | Stock Option (Right to Buy) | D | 9,10 | 400.000 | 400.000 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Ros Matthew | COGT | Stock Option (Right to Buy) | D | 7,62 | 1.641 | 1.641 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Ferrante Karen Jean | COGT | Stock Option (Right to Buy) | D | 7,62 | 1.575 | 1.575 | |||||
| 2020-12-09 | 2020-12-07 | 4 | Robbins Andrew R | COGT | Stock Option (Right to Buy) | D | 12,76 | 456.693 | 456.693 | |||||
| 2020-12-07 | 2020-12-01 | 4 | Green John L. | COGT | Common Stock | D | 1.748 | 1.748 | ||||||
| 2020-10-27 | 2020-10-23 | 4 | Robbins Andrew R | COGT | Stock Option (Right to Buy) | D | 2,79 | 7.442.421 | 7.442.421 | |||||
| 2020-10-15 | 2020-10-13 | 4 | Green John L. | COGT | Stock Option (Right to Buy) | D | 2,89 | 695.700 | 695.700 | |||||
| 2020-10-08 | 2020-05-12 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4638 | -98.200 | -46 | 3.095.114 | ||||
| 2020-10-08 | 2020-05-11 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4524 | -77.719 | -35 | 3.193.314 | ||||
| 2020-10-08 | 2020-05-11 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4639 | -22.281 | -10 | 3.271.033 | ||||
| 2020-10-08 | 2020-05-08 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4639 | -100.000 | -46 | 3.293.314 | ||||
| 2020-10-08 | 2020-05-07 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4143 | -100.000 | -41 | 3.393.314 | ||||
| 2020-10-08 | 2020-05-06 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4009 | -1.800 | -1 | 3.493.314 | ||||
| 2020-10-08 | 2020-05-05 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4018 | -135.484 | -54 | 3.495.114 | ||||
| 2020-10-08 | 2020-05-04 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4006 | -4.795 | -2 | 3.630.598 | ||||
| 2020-10-08 | 2020-05-01 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4100 | -800 | -0 | 3.635.393 | ||||
| 2020-10-08 | 2020-04-30 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4021 | -75.994 | -31 | 3.636.193 | ||||
| 2020-10-08 | 2020-04-29 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4061 | -382.927 | -156 | 3.712.187 | ||||
| 2020-10-08 | 2020-04-28 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4099 | -15.048 | -6 | 4.095.114 | ||||
| 2020-10-08 | 2020-04-27 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4032 | -242.579 | -98 | 4.110.162 | ||||
| 2020-10-08 | 2020-04-20 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4006 | -12.606 | -5 | 4.352.741 | ||||
| 2020-10-08 | 2020-04-17 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3902 | -65.540 | -26 | 4.365.347 | ||||
| 2020-10-08 | 2020-04-16 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3826 | -600 | -0 | 4.430.887 | ||||
| 2020-10-08 | 2020-04-15 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3841 | -82.782 | -32 | 4.431.487 | ||||
| 2020-10-08 | 2020-04-14 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4000 | -44.006 | -18 | 4.514.269 | ||||
| 2020-10-08 | 2020-04-14 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,4024 | -54.967 | -22 | 4.558.275 | ||||
| 2020-10-08 | 2020-04-09 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3287 | -420.292 | -138 | 4.613.242 | ||||
| 2020-10-08 | 2020-04-08 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3510 | -100 | -0 | 5.033.534 | ||||
| 2020-10-08 | 2020-04-07 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3500 | -11.400 | -4 | 5.033.634 | ||||
| 2020-10-08 | 2020-04-06 | 4 | CAMPANA DARIO By IPCT Holdings LLC | COGT | Common Stock | I | 0,3500 | -50.080 | -18 | 5.045.034 | ||||
| 2020-10-02 | 2020-10-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 2,26 | 1,3518 | 8.878 | 12 | 8.878 | |||
| 2020-10-02 | 2020-10-01 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 2,26 | 1,3518 | 9.247 | 13 | 9.247 | |||
| 2020-08-31 | 2020-08-27 | 4 | Harwin Peter Evan | UMRX | Director Stock Option (Right to Buy) | D | 2,77 | 28.661 | 28.661 | |||||
| 2020-08-31 | 2020-08-27 | 4 | CAIN CHRISTOPHER W. | UMRX | Director Stock Option (Right to Buy) | D | 2,77 | 28.661 | 28.661 | |||||
| 2020-08-18 | 2020-08-18 | 4 | Venrock Healthcare Capital Partners III, L.P. By funds | UMRX | Common Stock | I | 2,6200 | 101.000 | 265 | 4.355.273 | ||||
| 2020-08-18 | 2020-08-17 | 4 | Venrock Healthcare Capital Partners III, L.P. By funds | UMRX | Common Stock | I | 2,5700 | 250.000 | 642 | 4.254.273 | ||||
| 2020-08-18 | 2020-08-14 | 4 | Venrock Healthcare Capital Partners III, L.P. By funds | UMRX | Common Stock | I | 2,3000 | 100.000 | 230 | 4.004.273 | ||||
| 2020-08-18 | 3 | Shah Nimish P By funds | UMRX | Common Stock | I | 3.904.273 | ||||||||
| 2020-07-13 | 2020-07-09 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | UMRX | Series A Convertible Preferred Stock | I | 880,0000 | 19.035 | 16.751 | 55.500 | ||||
| 2020-07-13 | 2020-07-09 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | UMRX | Series A Convertible Preferred Stock | I | 880,0000 | 3.692 | 3.249 | 11.914 | ||||
| 2020-07-08 | 2020-07-06 | 4 | Green John L. | UMRX | Restricted Stock Units | D | -109.459 | 0 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Green John L. | UMRX | Common Stock | D | 2,2000 | -31.873 | -70 | 77.586 | ||||
| 2020-07-08 | 2020-07-06 | 4 | Green John L. | UMRX | Common Stock | D | 109.459 | 109.459 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | UMRX | Series A Convertible Preferred Stock | I | 36.465 | 36.465 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | UMRX | Series A Convertible Preferred Stock | I | 8.222 | 8.222 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | UMRX | Common Stock | I | 5.088.497 | 5.088.497 | ||||||
| 2020-07-08 | 2020-07-06 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | UMRX | Common Stock | I | 1.147.406 | 1.147.406 | ||||||
| 2020-07-06 | 2020-07-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 0,47 | 0,3118 | 61.338 | 19 | 61.338 | |||
| 2020-07-06 | 2020-07-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 0,47 | 0,3118 | 38.487 | 12 | 38.487 | |||
| 2020-07-06 | 2020-07-01 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 0,47 | 0,3118 | 35.280 | 11 | 35.280 | |||
| 2020-07-06 | 2020-07-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 0,47 | 0,3118 | 40.090 | 13 | 40.090 | |||
| 2020-06-11 | 2020-06-09 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14.331 | 14.331 | |||||
| 2020-06-11 | 2020-06-09 | 4 | Morris Arlene | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14.331 | 14.331 | |||||
| 2020-06-11 | 2020-06-09 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14.331 | 14.331 | |||||
| 2020-06-11 | 2020-06-09 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14.331 | 14.331 | |||||
| 2020-06-11 | 2020-06-09 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 0,63 | 14.331 | 14.331 | |||||
| 2020-04-08 | 2020-04-06 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 0,35 | 0,2205 | 86.735 | 19 | 86.735 | |||
| 2020-04-08 | 2020-04-06 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 0,35 | 0,2205 | 54.422 | 12 | 54.422 | |||
| 2020-04-08 | 2020-04-06 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 0,35 | 0,2205 | 49.887 | 11 | 49.887 | |||
| 2020-04-08 | 2020-04-06 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 0,35 | 0,2205 | 56.690 | 13 | 56.690 | |||
| 2020-02-13 | 2020-02-11 | 4 | Ettenberg Seth | UMRX | Stock Option | D | 0,80 | 153.600 | 153.600 | |||||
| 2020-02-13 | 2020-02-11 | 4 | Green John L. | UMRX | Stock Option | D | 0,80 | 64.400 | 64.400 | |||||
| 2020-02-13 | 2020-02-11 | 4 | HODGE GEOFFREY | UMRX | Stock Option | D | 0,80 | 112.400 | 112.400 | |||||
| 2020-02-13 | 2020-02-11 | 4 | Osborne Matthew Scott | UMRX | Stock Option | D | 0,80 | 160.400 | 160.400 | |||||
| 2020-02-13 | 2020-02-11 | 4 | Sachs Jessica | UMRX | Stock Option | D | 0,80 | 133.200 | 133.200 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 0,72 | 0,4532 | 39.996 | 18 | 39.996 | |||
| 2020-01-06 | 2020-01-02 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 0,72 | 0,4532 | 24.274 | 11 | 24.274 | |||
| 2020-01-06 | 2020-01-02 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 0,72 | 0,4532 | 29.790 | 14 | 29.790 | |||
| 2020-01-06 | 2020-01-02 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 0,72 | 0,4532 | 26.480 | 12 | 26.480 | |||
| 2019-11-21 | 2019-11-19 | 4 | Green John L. | UMRX | Restricted Stock Units | D | 109.459 | 109.459 | ||||||
| 2019-11-21 | 2019-11-19 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,69 | 280.000 | 280.000 | |||||
| 2019-10-03 | 2019-10-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 1,41 | 0,8794 | 20.611 | 18 | 20.611 | |||
| 2019-10-03 | 2019-10-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 1,41 | 0,8794 | 13.646 | 12 | 13.646 | |||
| 2019-10-03 | 2019-10-01 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 1,41 | 0,8794 | 12.509 | 11 | 12.509 | |||
| 2019-10-03 | 2019-10-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 1,41 | 0,8794 | 15.352 | 14 | 15.352 | |||
| 2019-07-29 | 2019-07-26 | 4 | Morris Arlene | UMRX | Stock Option (Right to Buy) | D | 2,05 | 28.661 | 28.661 | |||||
| 2019-07-29 | 2019-07-26 | 4 | Ros Matthew | UMRX | Stock Option (Right to Buy) | D | 2,05 | 28.661 | 28.661 | |||||
| 2019-07-22 | 2019-07-19 | 4 | Sachs Jessica | UMRX | Stock Option (Right to Buy) | D | 2,61 | 123.800 | 123.800 | |||||
| 2019-07-03 | 2019-07-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 2,41 | 1,7745 | 7.608 | 14 | 7.608 | |||
| 2019-07-03 | 2019-07-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 2,41 | 1,7745 | 10.285 | 18 | 10.285 | |||
| 2019-07-03 | 2019-07-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 2,41 | 1,7745 | 6.199 | 11 | 6.199 | |||
| 2019-06-25 | 2019-06-24 | 4 | Osborne Matthew Scott | UMRX | Stock Option (Right to Buy) | D | 2,44 | 190.000 | 190.000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 2,70 | 14.331 | 14.331 | |||||
| 2019-06-20 | 2019-06-18 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 2,70 | 14.331 | 14.331 | |||||
| 2019-06-20 | 2019-06-18 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 2,70 | 14.331 | 14.331 | |||||
| 2019-06-18 | 2019-06-14 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 2,43 | 1,6654 | 7.881 | 13 | 7.881 | |||
| 2019-06-18 | 2019-06-14 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 2,43 | 1,6654 | 7.131 | 12 | 7.131 | |||
| 2019-04-26 | 2019-04-24 | 4 | Green John L. | UMRX | Stock Option (Right to Buy) | D | 3,52 | 16.814 | 16.814 | |||||
| 2019-04-23 | 2019-04-19 | 4/A | Green John L. | UMRX | Stock Option (Right to Buy) | D | 3,60 | 21.017 | 21.017 | |||||
| 2019-04-11 | 2019-03-01 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 4,36 | 69.700 | 69.700 | |||||
| 2019-04-11 | 2019-03-01 | 4 | Green John L. | UMRX | Stock Option (Right to Buy) | D | 4,36 | 21.017 | 21.017 | |||||
| 2019-04-11 | 2019-03-01 | 4 | HODGE GEOFFREY | UMRX | Stock Option (Right to Buy) | D | 4,36 | 28.000 | 28.000 | |||||
| 2019-04-11 | 2019-03-01 | 4 | VASCONCELLES MICHAEL | UMRX | Stock Option (Right to Buy) | D | 4,36 | 61.900 | 61.900 | |||||
| 2019-04-11 | 2019-03-01 | 4 | WILSON CHARLES | UMRX | Stock Option (Right to Buy) | D | 4,36 | 174.400 | 174.400 | |||||
| 2019-04-03 | 2019-03-25 | 4/A | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | -11.485 | 329.145 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 4.047 | 11 | 4.047 | |||
| 2019-04-03 | 2019-04-01 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 4.369 | 12 | 4.369 | |||
| 2019-04-03 | 2019-04-01 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 4.829 | 13 | 4.829 | |||
| 2019-04-03 | 2019-04-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 4.966 | 14 | 4.966 | |||
| 2019-04-03 | 2019-04-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 4,40 | 2,7185 | 6.714 | 18 | 6.714 | |||
| 2019-03-26 | 2019-03-25 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | 11.485 | 329.145 | |||||
| 2019-03-26 | 2019-03-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 4,1214 | -11.485 | -47 | 0 | ||||
| 2019-03-26 | 2019-03-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11.485 | 2 | 11.485 | ||||
| 2019-02-26 | 2019-02-25 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | -11.485 | 340.630 | |||||
| 2019-02-26 | 2019-02-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 4,2536 | -11.485 | -49 | 0 | ||||
| 2019-02-26 | 2019-02-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11.485 | 2 | 11.485 | ||||
| 2019-01-04 | 2019-01-02 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 4.999 | 13 | 4.999 | |||
| 2019-01-04 | 2019-01-02 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 6.757 | 18 | 6.757 | |||
| 2019-01-04 | 2019-01-02 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 4.073 | 11 | 4.073 | |||
| 2019-01-04 | 2019-01-02 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 4.397 | 12 | 4.397 | |||
| 2019-01-04 | 2019-01-02 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 4,47 | 2,7000 | 4.860 | 13 | 4.860 | |||
| 2018-12-28 | 2018-12-26 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | -11.485 | 352.115 | |||||
| 2018-12-28 | 2018-12-26 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 4,0476 | -11.485 | -46 | 0 | ||||
| 2018-12-28 | 2018-12-26 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11.485 | 2 | 11.485 | ||||
| 2018-11-26 | 2018-11-26 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | -11.485 | 363.600 | |||||
| 2018-11-26 | 2018-11-26 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 7,0043 | -11.485 | -80 | 0 | ||||
| 2018-11-26 | 2018-11-26 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11.485 | 2 | 11.485 | ||||
| 2018-10-29 | 2018-10-25 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | -11.485 | 375.085 | |||||
| 2018-10-29 | 2018-10-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 8,4633 | -11.485 | -97 | 0 | ||||
| 2018-10-29 | 2018-10-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11.485 | 2 | 11.485 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 2.171 | 14 | 2.171 | |||
| 2018-10-03 | 2018-10-01 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 2.935 | 18 | 2.935 | |||
| 2018-10-03 | 2018-10-01 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 1.769 | 11 | 1.769 | |||
| 2018-10-03 | 2018-10-01 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 1.910 | 12 | 1.910 | |||
| 2018-10-03 | 2018-10-01 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 10,37 | 6,2200 | 2.111 | 13 | 2.111 | |||
| 2018-09-26 | 2018-07-26 | 4 | PEREZ ROBERT J | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 1.361 | 12 | 1.361 | |||
| 2018-09-26 | 2018-07-26 | 4 | Ratcliffe Liam | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 1.504 | 13 | 1.504 | |||
| 2018-09-26 | 2018-07-26 | 4 | Aldag Jorn | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 1.547 | 13 | 1.547 | |||
| 2018-09-26 | 2018-07-26 | 4 | Booth Bruce | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 2.092 | 18 | 2.092 | |||
| 2018-09-26 | 2018-09-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 12,4668 | -11.485 | -143 | 0 | ||||
| 2018-09-26 | 2018-09-25 | 4 | Ettenberg Seth | UMRX | Common Stock | D | 0,1800 | 11.485 | 2 | 11.485 | ||||
| 2018-09-26 | 2018-09-24 | 4 | Ettenberg Seth | UMRX | Stock Option (Right to Buy) | D | 0,18 | -11.485 | 386.570 | |||||
| 2018-09-26 | 2018-07-26 | 4 | Ferrante Karen Jean | UMRX | Stock Option (Right to Buy) | D | 14,57 | 8,7200 | 1.261 | 11 | 1.261 | |||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP | UMRX | Series B Preferred Stock | I | -877 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | UMRX | Series B Preferred Stock | I | -73.065 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Series B Preferred Stock | I | -13.505 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP | UMRX | Series A Preferred Stock | I | -35.614 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | UMRX | Series A Preferred Stock | I | -2.968.650 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Series A Preferred Stock | I | -548.702 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP | UMRX | Common Stock | I | 558 | 23.240 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP | UMRX | Common Stock | I | 22.682 | 22.682 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | UMRX | Common Stock | I | 46.534 | 1.937.235 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership | UMRX | Common Stock | I | 1.890.701 | 1.890.701 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Common Stock | I | 12,0000 | 94.052 | 1.129 | 452.115 | ||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Common Stock | I | 8.601 | 358.063 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP | UMRX | Common Stock | I | 349.462 | 349.462 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FIL Ltd | UMRX | Series B Preferred Stock | D | -42.931 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FIL Ltd | UMRX | Series A Preferred Stock | D | -1.744.310 | 0 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FIL Ltd | UMRX | Common Stock | D | 27.342 | 1.138.274 | ||||||
| 2018-04-05 | 2018-04-03 | 4 | FIL Ltd | UMRX | Common Stock | D | 1.110.932 | 1.110.932 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Series B Preferred Stock | D | -83.037 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Series A Preferred Stock | D | -3.184.446 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Common Stock | D | 12,0000 | 94.052 | 1.129 | 3.361.535 | ||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Common Stock | D | 83.037 | 3.267.483 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Atlas Venture Fund IX, L.P. | UMRX | Common Stock | D | 3.184.446 | 3.184.446 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Series B Preferred Stock | I | -83.037 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Series A Preferred Stock | I | -3.184.446 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Common Stock | I | 12,0000 | 94.052 | 1.129 | 3.361.535 | ||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Common Stock | I | 83.037 | 3.267.483 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Booth Bruce | UMRX | Common Stock | I | 3.184.446 | 3.184.446 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Series B Preferred Stock | I | -977.836 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Series B Preferred Stock | I | -977.835 | 0 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Common Stock | I | 12,0000 | 275.000 | 3.300 | 897.773 | ||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Common Stock | I | 12,0000 | 275.000 | 3.300 | 897.773 | ||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Common Stock | I | 622.773 | 622.773 | ||||||
| 2018-04-03 | 2018-04-03 | 4 | Ratcliffe Liam | UMRX | Common Stock | I | 622.772 | 622.772 | ||||||
| 2018-03-28 | 3 | CAMPANA DARIO | UMRX | Common Stock | D | 10.190.228 | ||||||||
| 2018-03-28 | 3 | CAMPANA DARIO | UMRX | Common Stock | D | 10.190.228 | ||||||||
| 2018-03-28 | 3 | CAMPANA DARIO | UMRX | Common Stock | D | 10.190.228 | ||||||||
| 2018-03-28 | 3 | WILSON CHARLES | UMRX | Common Stock | D | 10.190.228 | ||||||||
| 2018-03-28 | 3 | WILSON CHARLES | UMRX | Common Stock | D | 10.190.228 | ||||||||
| 2018-03-28 | 3 | WILSON CHARLES | UMRX | Common Stock | D | 10.190.228 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
